{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:23:42Z","timestamp":1789939422311,"version":"4.0.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.00741","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T07:27:51Z","timestamp":1524554871000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model"],"prefix":"10.3389","volume":"9","author":[{"given":"David","family":"Gur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai","family":"Glinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Aftalion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Vagima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinon","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahar","family":"Rotem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayelet","family":"Zauberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avital","family":"Tidhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Tal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Maoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuelle","family":"Mamroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1365-2125.1995.tb05719.x","article-title":"A suggested approach to once-daily aminoglycoside dosing","volume":"39","author":"Begg","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3390\/pharmaceutics8010006","article-title":"Development of liposomal ciprofloxacin to treat lung infections","volume":"8","author":"Cipolla","year":"2016","journal-title":"Pharmaceutics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1128\/CMR.00022-14","article-title":"Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients","volume":"27","author":"Dalhoff","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fmicb.2017.00091","article-title":"Inhaled liposomal ciprofloxacin protects against a lethal infection in a murine model of pneumonic plague","volume":"8","author":"Hamblin","year":"2017","journal-title":"Front. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jcf.2014.04.004","article-title":"Inhaled versus nebulised tobramycin: a real world comparison in adult cystic fibrosis (CF)","volume":"13","author":"Harrison","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcf.2010.10.003","article-title":"Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: the EAGER trial","volume":"10","author":"Konstan","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1086\/428617","article-title":"Risk of person-to-person transmission of pneumonic plague","volume":"40","author":"Kool","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"16669","DOI":"10.1073\/pnas.0607898104","article-title":"Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract","volume":"104","author":"Lane","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"17786","DOI":"10.1073\/pnas.0506840102","article-title":"Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity","volume":"102","author":"Lathem","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrd2153","article-title":"Inhaling medicines: delivering drugs to the body through the lungs","volume":"6","author":"Patton","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis-etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"B13","first-page":"59","article-title":"Plague studies. VIII. Clinical aspects","volume":"9","author":"Pollitzer","year":"1953","journal-title":"Bull. World Health Organ."},{"key":"B14","first-page":"53","article-title":"Regional deposition of inhaled mono-dispersed coarse anf fine aerosol particles in small laboratory animals","volume":"32","author":"Raabe","year":"1988","journal-title":"Ann. Occup. Hyg."},{"key":"B15","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2165\/11594090-000000000-00000","article-title":"Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents","volume":"50","author":"Rodvold","year":"2011","journal-title":"Clin. Pharmacokinet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1152\/physrev.00041.2010","article-title":"Hypoxic pulmonary vasoconstriction","volume":"92","author":"Sylvester","year":"2012","journal-title":"Physiol. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2807\/1560-7917.ES.2017.22.46.17-00710","article-title":"Dynamics of the pneumonic plague epidemic in Madagascar, August to October 2017","volume":"22","author":"Tsuzuki","year":"2017","journal-title":"Euro. Surveill."},{"key":"B19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fcimb.2012.00143","article-title":"Early sensing of Yersinia pestis airway infection by bone marrow cells","volume":"2","author":"Vagima","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1004893","DOI":"10.1371\/journal.ppat.1004893","article-title":"Circumventing Y. pestis virulence by early recruitment of neutrophils to the lungs during pneumonic plague","volume":"11","author":"Vagima","year":"2015","journal-title":"PLoS Pathog."},{"key":"B21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1586\/eri.11.126","article-title":"Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia","volume":"9","author":"Wood","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijmm.2016.11.002","article-title":"Host transcriptomic responses to pneumonic plague reveal that Yersinia pestis inhibits both the initial adaptive and innate immune responses in mice","volume":"307","author":"Yang","year":"2017","journal-title":"Int. J. Med. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fcimb.2017.00277","article-title":"Host iron nutritional immunity induced by a live Yersinia pestis vaccine strain is associated with immediate protection against plague","volume":"7","author":"Zauberman","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00741\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T23:05:46Z","timestamp":1571267146000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00741\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":23,"alternative-id":["10.3389\/fmicb.2018.00741"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.00741","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]},"article-number":"741"}}